Revlimid
Trial Is Assessing KRd Versus KCd in Newly Diagnosed MM Pts
Chicago—As an induction therapy in newly diagnosed, relatively young patients with multiple myeloma (MM), ...
JUNE 30, 2017
Long-Term Efficacy and Safety of ELd in RRMM Confirmed
Adding elotuzumab (Empliciti, Bristol-Myers Squibb) to lenalidomide (Revlimid, Celgene) and dexamethasone (ELd) ...
JUNE 26, 2017
Darzalex Approved With Pomalyst and Dex for Third-Line MM Rx
Approved in combination with pomalidomide (Pomalyst, Celgene) and dexamethasone for patients with multiple myeloma ...
JUNE 19, 2017
Load more